Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

We have investigated whether the vessel wall may release or synthetize some substance able to modify the platelet function independent of prostacyclin (PGI2) production. Twenty female rats were injected with indomethacin. 18 hours after the injection animals were sacrified and rings cut from thoracic and abdominal aorta were obtained. They were incubated in Krebs solution for different periods of time after which an aliquot from the indomethacin treated rat's aortic ring (ITRAR) was assayed on platelet aggregation induced by several agonists. The supernatant from the 40 min. incubation mixture of ITRAR released a substance which completely inhibits platelet aggregation induced by arachidonic acid (AA), ADP, epinephrine, collagen, ristocetin and thrombin. The time of appearance of the substance varied with a mean of 17 min. It is released with and without AA stimulation. Once generated it is active for at least three hours; its antiaggregating activity remains even if it is boiled for 15 sec, incubated at 37°C, or if the vessel is treated with tranylcypromine. Platelet aggregation inhibition is still evident if the supernatant from ITRAR is transferred to a platelet rich plasma (PRP) from a normal donor who had taken an aspirin 24 hours before sampling. All these results indicate that this substance released from ITRAR is not prostacyclin. Nordihydroguaiaretic or eicosatetraynoic acid which are lipoxygenase inhibitors could not modify the ITRAR's release; nor did mepacrine which is a phospholipase inhibitor. Since mepacrine does not completely inhibit phospholipase activities we cannot exclude the possibility that the substance is derived from AA. More studies are in progress to elucidate the biochemical properties of this substance. © 1985.

Registro:

Documento: Artículo
Título:Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
Autor:Schattner, M.A.; Gimeno, M.; Lazzari, M.A.
Filiación:Sección Hemostasia y Trombosis, Academia Nacional de Medicina, Centro de Estudios Farmacológicos y de Principios Naturales, Pacheco de Melo 3081, 1425 Buenos Aires, Argentina
Palabras clave:adenosine diphosphate; adrenalin; arachidonic acid; collagen; icosatetraynoic acid; mepacrine; nordihydroguaiaretic acid; prostacyclin; thrombin; tranylcypromine; animal cell; aorta; blood and hemopoietic system; blood vessel; cardiovascular system; drug efficacy; great blood vessel; inhibition; nonhuman; priority journal; rat; thrombocyte aggregation; 5,8,11,14-Eicosatetraynoic Acid; Animal; Aorta; Aspirin; Catechols; Endothelium; Female; Human; In Vitro; Indomethacin; Nordihydroguaiaretic Acid; Platelet Aggregation; Rats
Año:1985
Volumen:19
Número:3
Página de inicio:251
Página de fin:260
DOI: http://dx.doi.org/10.1016/0262-1746(85)90138-6
Título revista:Prostaglandins, Leukotrienes and Medicine
Título revista abreviado:Prostaglandins Leukotrienes Med.
ISSN:02621746
CODEN:PLMED
CAS:adenosine diphosphate, 20398-34-9, 58-64-0; adrenalin, 51-43-4, 55-31-2, 6912-68-1; arachidonic acid, 506-32-1, 6610-25-9, 7771-44-0; collagen, 9007-34-5; icosatetraynoic acid, 52642-57-6; mepacrine, 69-05-6, 83-89-6; nordihydroguaiaretic acid, 500-38-9; prostacyclin, 35121-78-9, 61849-14-7; thrombin, 9002-04-4; tranylcypromine, 13492-01-8, 155-09-9, 54-97-7; 5,8,11,14-Eicosatetraynoic Acid, 1191-85-1; Aspirin, 50-78-2; Catechols; Indomethacin, 53-86-1; Nordihydroguaiaretic Acid, 500-38-9
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02621746_v19_n3_p251_Schattner

Referencias:

  • Moncada, Gryglewski, Bunting, Vane, An enzyme isolated from ateries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation (1976) Nature, 263, p. 663
  • Loskutoff, Edgington, Synthesis of a fibrinolytic activator by endothelial cells (1977) Proc. Natl. Acad. Sci. USA, 74, p. 3903
  • Jaffe, Hoyer, Nachman, Synthesis of antihemophilic factor antigen by cultured human endothelial cells (1973) J. Clin. Invest., 52, p. 2757
  • Damus, Hicks, Rosenberg, Anticoagulant action of heparin (1973) Nature (Scand), 246, p. 355
  • Owen, Esmon, Functional properties of an endothelial cell cofactor for thrombin-catalized activation of protein C (1981) J. Biol. Chem, 256, p. 5532
  • Maynard, Dreyer, Stemerman, Pitleck, Tissue factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts (1977) Blood, 50, p. 387
  • Goodnough, Kleinheuz, Goldsmith, Zvats, Robertson, Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity (1984) J.Clin. Invest., 74, p. 75
  • Born, Cross, The aggregation of blood platelets (1963) J. Physiol., 168, p. 178
  • Moncada, Higgs, Vane, Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation (1977) The Lancet, 1, p. 18
  • Gryglewski, Bunting, Moncada, Flower, Vane, Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from protaglandin endoperoxides (1976) Prostaglandins, 12, p. 685
  • Weksler, Marcus, Jaffe, Synthesis of prostaglandin 12 (prostacyclin) by cultured human and bovine endothelial cells (1977) Proc.Natl.Acad.Sci. USA, 74, p. 3922
  • Moncada, Vane, Unstable metabolites or arachidonic acid and their role in haemostasis and thrombosis (1978) Br. Med. Bull., 34, p. 129
  • Moncada, Vane, The role of prostacyclin in vascular tissue (1979) Fedn. Proc. Fedn. Am. Socs. Exp. Biol., 38, p. 62
  • Heyns, Du, Van der Berg, Potgieter, Retief, The inhibition of platelet aggregation by an aorta intima extract (1974) Thromb. Diathes. Haemorrh., 32, p. 417
  • Lieberman, Lewis, Peters, A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate induced platelet aggregation (1977) The Lancet, 2, p. 330
  • Packman, Kinlough-Rathbone, Reimers, Scott, Mustard, Mechanisms of platelet aggregation independent of adenosine diphosphate (1977) Prostaglandins in hematology, p. 247. , M.J. Silver, J.B. Smith, J.J. Koesis, Spectrum Publications Inc, New York
  • Wynalda, Fitzpatrick, Albumins stabilize prostaglandin I2 (1980) Prostaglandins, 20, p. 853
  • Gimeno, Sterin Borda, Borda, Lazzari, Gimeno, Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries (1980) Prostaglandins, 19, p. 907
  • Moncada, Prostacyclin and arterial wall biology (1982) Arterioesclerosis, 2, p. 193
  • Ferreira, Moncada, Vane, Indomethacin and aspirin abolish prostaglandin release from the spleen (1971) Nature New Biol., 231, p. 237

Citas:

---------- APA ----------
Schattner, M.A., Gimeno, M. & Lazzari, M.A. (1985) . Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production. Prostaglandins, Leukotrienes and Medicine, 19(3), 251-260.
http://dx.doi.org/10.1016/0262-1746(85)90138-6
---------- CHICAGO ----------
Schattner, M.A., Gimeno, M., Lazzari, M.A. "Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production" . Prostaglandins, Leukotrienes and Medicine 19, no. 3 (1985) : 251-260.
http://dx.doi.org/10.1016/0262-1746(85)90138-6
---------- MLA ----------
Schattner, M.A., Gimeno, M., Lazzari, M.A. "Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production" . Prostaglandins, Leukotrienes and Medicine, vol. 19, no. 3, 1985, pp. 251-260.
http://dx.doi.org/10.1016/0262-1746(85)90138-6
---------- VANCOUVER ----------
Schattner, M.A., Gimeno, M., Lazzari, M.A. Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production. Prostaglandins Leukotrienes Med. 1985;19(3):251-260.
http://dx.doi.org/10.1016/0262-1746(85)90138-6